In contrast, the frequencies of tumor-infiltrating macrophages as well as CD11b+ Gr1+ myeloid-derived suppressor cells (MDSC) were not affected early after therapy initiation (Fig. 3c, d). Here, ITGAM is linked to neoplasm.